Should men at risk for cardiovascular disease receive earlier cholesterol treatment?

July 22, 2014
Credit: 2014 Mary Ann Liebert, Inc., publishers

New guidelines on cholesterol treatment and cardiovascular risk assessment state that men have at least double the risk of dying from atherosclerotic cardiovascular disease or of having a heart attack or stroke as do women with a similar risk profile (based on age, smoking history, and cholesterol and blood pressure levels). The implications of this finding for when and how aggressively to treat high cholesterol are examined in an Editorial in Journal of Men's Health.

Stephen L. Kopecky, MD, Mayo Clinic, Rochester, MN, and Ajay Nehra, MD, Rush University Medical Center, Chicago, IL, discuss the risk factors on which the American College of Cardiology and the American Heart Association based their new guidelines. They describe the value in developing 10-year risk and lifetime risk estimates and their use in educating patients and encouraging lifestyle changes.

The authors note the omission of erectile dysfunction as a risk marker, and they explain the new recommendations in the Editorial entitled "Cardiovascular Risk and Cholesterol Management in Men: Implications of the New Guidelines."

Explore further: Cholesterol guidelines are based on strong, evidence-based science, AHA says

More information: The article is available free on the Journal of Men's Health website at until August 22, 2014.

Related Stories

Niacin too dangerous for routine cholesterol therapy

July 16, 2014

After 50 years of being a mainstay cholesterol therapy, niacin should no longer be prescribed for most patients due to potential increased risk of death, dangerous side effects and no benefit in reducing heart attacks and ...

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.